KRISTY CHAPPELL: Open Payments
NPI 1073514030 · POWDERLY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 59 payments from 16 companies in 2025. Trend: 2023 $989 · 2024 $922 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $246 |
| Novo Nordisk Inc | 9 | $159 |
| Amgen Inc. | 11 | $146 |
| Ardelyx, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $47 |
| PFIZER INC. | 2 | $33 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
Products named: VRAYLAR, OTEZLA, QULIPTA, IBSRELA, Wegovy, MOUNJARO, Rybelsus, EVENITY.
Industry payments across KY — which companies pay providers there.
